- €27.53bn
- €59.81bn
- €47.64bn
- 34
- 63
- 28
- 33
REG - Stock Exch Notice - Admission to ISM - 29/01/2024
AnnouncementRCS - Viralgen Vector Core - Viralgen welcomes back Andy Holt as CCO
AnnouncementRCS - Viralgen Vector Core - Viralgen & Elpida Partner for SPG50 & CMT4J Trials
AnnouncementREG - Stock Exch Notice - Admission to ISM - 21/09/2023
AnnouncementREG - Stock Exch Notice - Admission to ISM - 06/07/2023
AnnouncementREG - Deutsche Bank AG FF - Post Stabilisation Notice - Bayer EUR 3 Tranches
AnnouncementRCS - Access Accelerated - Access Accelerated Releases Six-Year Report
AnnouncementREG - Deutsche Bank AG FF - Pre Stabilisation Notice - Bayer EUR 3 Tranches
AnnouncementRCS - Viralgen Commercial - Viralgen GMP certification rAAV commercial product
AnnouncementREG - Deutsche Bank AG FF - Post Stabilisation Notice - Covestro EUR 500M 6y
AnnouncementREG - Deutsche Bank AG FF - Pre Stab Notice - Covestro EUR 500M 6y Green
AnnouncementREG - M&G PLC - Director/PDMR Shareholding
AnnouncementRCS - artnet AG - Artnet AG Publishes ESG Report
AnnouncementREG - Morgan StanleyEurope - Stabilisation Notice
AnnouncementREG - Morgan StanleyEurope - Stabilisation Notice
AnnouncementREG - European Opps. Trust - Portfolio Update
AnnouncementREG - European Opps. Trust - Portfolio Update
AnnouncementREG - European Opps. Trust - Portfolio Update
AnnouncementREG - European Opps. Trust - Portfolio Update
Announcement